首页|期刊导航|中国病毒学|SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PAOA

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA

Liubing Du;Zhenyu He;Zhanjia Zhang;Yu Yan;Qitong Lin;Yushan Xue;Deyin Guo;Ji-An Pan;Yao-Qing Chen;Xiaoxue Peng;Xiaoyu Cai;Ziliang Peng;Mengxuan Wang;Huijie Li;Xue Liu;Zhihui Zhang;Manqi Cao;Shuchun Zhang

The Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,China||The Division of Basic Research,Guangzhou National Laboratory,Bio-island,Guangzhou 510320,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Division of Basic Research,Guangzhou National Laboratory,Bio-island,Guangzhou 510320,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,China||The Center for Infection and Immunity Study,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaSchool of Public Health(Shenzhen),Shenzhen Campus of Sun Yat-sen University,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,China||The Center for Infection and Immunity Study,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,China||Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases,Shenzhen Campus of Sun Yat-sen University,Shenzhen 518107,ChinaSchool of Public Health(Shenzhen),Shenzhen Campus of Sun Yat-sen University,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Center for Infection and Immunity Study,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,ChinaThe Molecular Cancer Research Center,Zhongshan School of Medicine,Sun Yat-sen University Shenzhen Campus,Shenzhen 518107,China

SARS-CoV-2Influenza virus3C-like protease(3CLpro)Nucleoprotein(NP)Polymerase acidic protein(PA)

SARS-CoV-2Influenza virus3C-like protease(3CLpro)Nucleoprotein(NP)Polymerase acidic protein(PA)

《中国病毒学》 2026 (4)

842-854,13

This work was supported by grants:National Key R&D Program of China(2025YFC2311600 for XP),China Postdoctoral Science Fund(2023M744081 for LD),Natural Science Foundation of China(#92569303 for YQC,#82150204 for XP,#32370159 and#82341057 for JAP and LD),Major Project of Guangzhou National Laboratory(GZNL2024A01008 for JAP),Regional Joint Key Project of Guangdong Province(2022B1515120038 for JAP),Shenzhen science and technol-ogy planning project(ZDSYS20220606100803007 for XP)and Shenz-hen Medical Research Fund(B2302044 for YQC,A2501026 for YY,and A2401035 for ZZ).

10.1016/j.virs.2026.08.006

评论